Polyhydroxyalkanoate composition, polyhydroxyalkanoate molded article and preparation method therefor

By using lactic acid or its organic derivatives as nucleating agents, the problems of low crystallization rate and low processing and curing efficiency of polyhydroxy fatty acid ester are solved, efficient crystallization and simple processing process are achieved, and the performance of the molded body is improved and application value.

WO2024245225A1PCT designated stage expired Publication Date: 2024-12-05SHANGHAI BLUEPHA MICROBIOLOGY TECH CO LTD +1
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2024/095714
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-29
Filing Date
2024-05-28
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

In the prior art, the crystallization rate and processing and curing efficiency of polyhydroxy fatty acid esters are low, and commonly used nucleating agents will lead to a reduced transparency of the molded body color and affect application.

Method used

Lactic acid or its organic derivatives are used as nucleating agents to promote its crystallization and increase the crystallization rate and crystallinity by combining with specific structural units in the polyhydroxy fatty acid ester composition.

Benefits of technology

The crystallization speed and crystallinity of the polyhydroxy fatty acid ester molded body are significantly improved, the crystallization temperature is reduced, the processing process is simplified, the processing efficiency is improved, and energy consumption is reduced.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure PCTCN2024095714-FTAPPB-I100001
    Figure PCTCN2024095714-FTAPPB-I100001
  • Figure PCTCN2024095714-FTAPPB-I100002
    Figure PCTCN2024095714-FTAPPB-I100002
  • Figure PCTCN2024095714-FTAPPB-I100003
    Figure PCTCN2024095714-FTAPPB-I100003
Patent Text Reader

Abstract

The present invention relates to the technical field of bio-based polymer materials, and specifically disclosed are a polyhydroxyalkanoate composition, a polyhydroxyalkanoate molded article, and a preparation method therefor. The polyhydroxyalkanoate composition of the present invention comprises polyhydroxyalkanoate, and at least one of lactic acid or an organic derivative of lactic acid. When lactic acid or a derivative thereof is used as a nucleating agent, the crystallization rate and crystallinity of the polyhydroxyalkanoate during preparation of the molded article can be significantly increased, and the crystallization temperature of polyhydroxyalkanoate having a broad melting range can be reduced, effectively shortening curing time of the molded article; this has the advantages of high nucleation efficiency, a simpler and more convenient processing approach, and reduced energy consumption.
Need to check novelty before this filing date? Find Prior Art

Description

A polyhydroxyalkanoate composition, a polyhydroxyalkanoate formed body and a preparation method thereof

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims priority to Chinese patent application No. 202310621212.0, filed on May 29, 2023, entitled “A polyhydroxyalkanoate composition, a polyhydroxyalkanoate molded body and a method for preparing the same”, the entire contents of which are incorporated herein by reference in their entirety to the same extent as if fully set forth herein. Technical Field

[0003] The present invention relates to the technical field of bio-based polymer materials, and in particular to a polyhydroxyalkanoate composition, a polyhydroxyalkanoate formed body and a preparation method thereof. Background Art

[0004] Polyhydroxyalkanoate (PHA) is an intracellular polyhydroxyalkanoate synthesized by many microorganisms and is a natural polymer biomaterial. Most monomers of polyhydroxyalkanoate are 3-hydroxy fatty acids with a chain length of 3 to 14 carbon atoms. Their side chains are highly variable saturated or unsaturated, linear or branched, aliphatic or aromatic groups. The diversity of the composition structure brings about the diversity of performance, which gives it obvious advantages in application. At the same time, polyhydroxyalkanoate is a bio-based polymer that is biodegradable in the marine environment. It can solve the environmental problems caused by discarded plastics and has excellent biocompatibility and mechanical properties. Therefore, polyhydroxyalkanoate can be processed into various molded bodies, such as films, straws, tableware, etc.

[0005] Controlling the crystallization rate is an important factor in the processing rate of polyhydroxyalkanoates. In the prior art, the crystallization rate of PHA is often increased by adding additives such as nucleating agents.

[0006] Nucleating agents used in existing technologies are primarily inorganic or metal salts. While these can improve the crystallization rate and crystallinity of conventional polyhydroxyalkanoate (PHA) shaped bodies to a certain extent, the improvement is limited. Furthermore, these shaped bodies can also become discolored, reducing their transparency and hindering their application. Furthermore, the preparation of polyhydroxyalkanoate (PHA) materials with a wide melting range often presents challenges such as low processing efficiency, difficulty achieving a high degree of curing, and prolonged curing times.

[0007] Summary of the Invention

[0008] In response to the problems existing in the prior art, one of the objectives of the present invention is to provide a polyhydroxyalkanoate composition comprising lactic acid and / or an organic derivative of lactic acid, which can effectively solve the problems of low crystallization rate and low processing and curing efficiency of polyhydroxyalkanoates.

[0009] A second object of the present invention is to provide a polyhydroxyalkanoate shaped body prepared from the polyhydroxyalkanoate composition.

[0010] The third object of the present invention is to provide a method for preparing the above-mentioned polyhydroxyalkanoate molded body.

[0011] In order to achieve the above object, the technical solution adopted by the present invention is as follows:

[0012] In a first aspect, the present invention provides a polyhydroxyalkanoate composition comprising:

[0013] Polyhydroxyalkanoate; and at least one of lactic acid or an organic derivative of lactic acid represented by the following general formula I: R 2 CH2-CH(OH)-COYR 1 I

[0014] Among them, R 1 is H or hydrocarbon group, R 2 is H or a hydrocarbon group, and Y is any one of C, O, N, and S.

[0015] In the present invention, R in the general formula I 1 、R 2 are H or C1-C16 short-chain hydrocarbon groups, and Y is any one of C, O, N, and S. That is, the composition includes short-chain ketones, esters / acids, sulfur-containing, and nitrogen-containing organic lactic acid derivatives represented by general formula I.

[0016] In the present invention, Y in the general formula I is O, R 1 、R 2 H, respectively, are lactic acid. Lactic acid can be divided into two categories based on its chiral structure: L-lactic acid and D-lactic acid. In the present invention, the lactic acid is selected from L-lactic acid, D-lactic acid, or a combination thereof; wherein, in the combination of L-lactic acid and D-lactic acid, the ratio of L-lactic acid to D-lactic acid is 0.01 to 99.99:99.99 to 0.01.

[0017] In the present invention, the lactic acid derivatives can further be divided into organic ester derivatives and organic acid derivatives of lactic acid.

[0018] In the general formula I, Y is O, R 1 is a C1-C16 hydrocarbon group, that is, the organic derivative of lactic acid is a structure of R 2 CH2-CH(OH)-COOR 1 Lactic acid ester derivatives, wherein R 2 is H or a C1-C16 hydrocarbon group; and / or,

[0019] In the general formula I, Y is O, R1 H, R 2 is a C1-C16 hydrocarbon group, that is, the structure of the organic lactic acid derivative is R 2 CH2-CH(OH)-COOH lactic acid organic acid derivatives.

[0020] The organic ester derivatives of lactic acid of the present invention include lactic acid (including L-lactic acid, D-lactic acid or any combination thereof, preferably L-lactic acid) substituted with a structure of R 2 CH2-CH(OH)-COOR 1 Lactic acid ester derivatives, wherein R 1 is a C1-C16 hydrocarbon group, R 2 is H or C1-C16 hydrocarbon group, R 1 、R 2 Preferably, the organic lactate derivative is a C1-C10 hydrocarbon group, a C1-C8 hydrocarbon group, or a C1-C4 hydrocarbon group, and examples thereof include methyl, ethyl, propyl, butyl, isopentyl, phenyl, benzyl, tetradecyl, and hexadecyl. In some specific embodiments, the organic lactate derivative may be methyl lactate, ethyl lactate, propyl lactate, butyl lactate, isopentyl lactate, benzyl lactate, tetradecyl lactate, hexadecyl lactate, or methyl 3-phenyllactate.

[0021] In the present invention, the organic acid derivatives of lactic acid include organic acid derivatives formed by retaining the lactic acid hydroxyl group and carboxyl group in lactic acid (including L-lactic acid, D-lactic acid or any combination thereof, preferably L-lactic acid), and the structure is R 2 CH2-CH(OH)-COOH, where R 2 It is a C1-C16 hydrocarbon group, more preferably a C1-C10 hydrocarbon group, a C1-C8 hydrocarbon group, or a C1-C4 hydrocarbon group, and examples thereof include methyl, ethyl, propyl, butyl, and phenyl groups, and specifically 3-phenyllactic acid.

[0022] In addition to the organic lactic acid derivatives exemplified above, it can be inferred that when Y in the general formula I is C, N, or S (carbon, nitrogen, or sulfur), the organic derivatives also have structures similar to the organic derivatives exemplified above (Y is O), and all retain the α-hydroxyl group of the organic lactic acid derivatives. It can be inferred that similar effects can be achieved. Therefore, the present invention should not be limited to the specific organic lactic acid derivatives exemplified above.

[0023] In a specific embodiment, the composition comprises lactic acid.

[0024] In a specific embodiment, the composition comprises L-lactic acid, D-lactic acid, or a mixture thereof in any proportion, for example, the ratio of L-lactic acid:D-lactic acid is 0.01-99.99:99.99-0.01, preferably 0.1-1:1-0.1, for example, it can be 0.1:1, 1:9, 1:8, 1:5, 1:4, 0.5:1, 1:1, 1:0.5, 4:1, 5:1, 8:1, 9:1, 1:0.1.

[0025] In a specific embodiment, the composition comprises any one selected from L-lactic acid, D-lactic acid, DL-lactic acid, or a combination thereof; wherein DL-lactic acid is lactic acid with a ratio of L-lactic acid to D-lactic acid of 1:1.

[0026] In a specific embodiment, the composition comprises L-lactic acid.

[0027] In a specific embodiment, in the composition, lactic acid or a lactic acid derivative acts as a nucleating agent.

[0028] In a specific embodiment, the amount of lactic acid and / or lactic acid derivatives added is 0.01%-20% of the mass of the polyhydroxyalkanoate; preferably 0.1%-10%; further preferably 0.1%-3%, for example 0.1%-2%, 0.1%-1.5%, 0.5%-1.5%; typically, but not limiting, the amount of lactic acid and / or lactic acid derivatives added, for example, can be 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.7%, 1%, 1.2%, 1.5%, 2%, 2.5%, 3% of the mass of the polyhydroxyalkanoate.

[0029] The polyhydroxyalkanoate of the present invention may be a single polymer or a composition of two or more polymers, wherein each polymer may contain one or more monomers (ie, one or more structural units in the polymer).

[0030] Specifically, any polymer contains a structural unit represented by the following general formula II:

[0031] In general formula II, R represents C p H 2p+1 In the alkyl group shown in FIG, p represents an integer of 1 to 15, preferably an integer of 1 to 10, and more preferably an integer of 1 to 8. Examples of R include linear or branched alkyl groups such as methyl, ethyl, propyl, butyl, isobutyl, tert-butyl, pentyl, and hexyl;

[0032] m is 1, 2 or 3; when m=1, general formula II represents a 3-hydroxyalkanoate structural unit, when m=2, general formula II represents a 4-hydroxyalkanoate structural unit, and when m=3, general formula II represents a 5-hydroxyalkanoate structural unit; among them, 3-hydroxyalkanoate structural units and 4-hydroxyalkanoate structural units are more common, such as 3-hydroxybutyrate structural units (hereinafter sometimes referred to as 3HB) and 4-hydroxybutyrate structural units (hereinafter sometimes referred to as 4HB).

[0033] In a specific embodiment, the polyhydroxyalkanoate of the present invention comprises at least one poly(3-hydroxyalkanoate).

[0034] Furthermore, the poly(3-hydroxyalkanoate) contains only 3-hydroxybutyrate structural units, or contains 3-hydroxybutyrate structural units and other hydroxyalkanoate structural units.

[0035] Furthermore, the other hydroxyalkanoate structural units include: one or more of 3-hydroxypropionate, 3-hydroxyvalerate, 3-hydroxyhexanoate, 3-hydroxyheptanoate, 3-hydroxyoctanoate, 3-hydroxynonanoate, 3-hydroxydecanoate, 3-hydroxyundecanoate or 4-hydroxybutyrate; preferably 3-hydroxyhexanoate.

[0036] Specifically, specific examples of poly(3-hydroxyalkanoates) include poly(3-hydroxybutyrate), poly(3-hydroxybutyrate-co-3-hydroxypropionate), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (abbreviation: P3HB3HV), poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate), poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (abbreviation: P3HB3HH), poly(3-hydroxybutyrate-co-3-hydroxyheptanoate), poly(3-hydroxybutyrate-co-3-hydroxyoctanoate), poly(3-hydroxybutyrate-co-3-hydroxynonanoate), poly(3-hydroxybutyrate-co-3-hydroxydecanoate), poly(3-hydroxybutyrate-co-3-hydroxyundecanoate), and poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (abbreviation: P3HB4HB). In particular, poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) is preferred from the viewpoints of processability and mechanical properties.

[0037] The lactic acid or organic lactic acid derivatives in the compositions of the present invention generally accelerate crystallization, regardless of the proportion of structural monomers in the polyhydroxyalkanoate in the composition. This may be because the specific structures contained in lactic acid or its organic derivatives are able to better "bind" with the polyhydroxyalkanoate, thus tending to "induce" the crystallization of the polyhydroxyalkanoate. The production method of the polyhydroxyalkanoate of the present invention is not particularly limited and can be a production method utilizing chemical synthesis or a production method utilizing microorganisms. Polyhydroxyalkanoates produced by microorganisms are particularly preferred, in which the 3-hydroxyalkanoate structural units in the polyhydroxyalkanoate produced by microorganisms are all contained in the form of (R)3-hydroxyalkanoate structural units. The poly(3-hydroxyalkanoate) includes a copolymer of a 3-hydroxybutyrate structural unit and other structural units, and in the poly(3-hydroxyalkanoate), the average content ratio of the 3-hydroxybutyrate structural unit to the other structural units is 50 / 50 to 99 / 1 (mol% / mol%), preferably 80 / 20 to 94 / 6 (mol% / mol%); when the polyhydroxyalkanoate raw material is a mixture of two or more polyhydroxyalkanoates, the average content ratio refers to the molar ratio of each monomer contained in the entire mixture.

[0038] Furthermore, the polyhydroxyalkanoate has a weight-average molecular weight of 100,000 to 1,000,000 Da, preferably 200,000 to 900,000 Da, and more preferably 300,000 to 800,000 Da or 600,000 to 800,000 Da. A weight-average molecular weight of less than 100,000 Da tends to reduce the mechanical properties of the resulting polyhydroxyalkanoate resin molded article. On the other hand, a weight-average molecular weight exceeding 1,000,000 Da tends to increase the load on machinery during melt processing, resulting in reduced productivity.

[0039] The polyhydroxyalkanoate composition of the present invention can be prepared using conventional techniques and equipment known in the art. For example, the powder can be directly mixed in a mixing device and then further blended in a high-speed mixer at room temperature.

[0040] In order to facilitate the processing of the polyhydroxyalkanoate composition of the present invention into a molded body, the polyhydroxyalkanoate composition may further include certain additives to increase the fluidity of the material and facilitate molding.

[0041] Furthermore, the auxiliary agents may be: dispersants, plasticizers, internal lubricants, external lubricants, release agents and other auxiliary agents that are conducive to fluidity; for example, specific auxiliary agents may be: vinyl bisstearamide (EBS), erucamide, oleamide, linoleamide, palmitamide, stearamide and other amides, polyethylene wax, rice bran wax, 8024 (amide wax rheological additive), silicone oil auxiliary agents, stearic acid, stearate, epoxidized soybean oil and other auxiliary agents with dispersing and lubricating effects. One or more of the above.

[0042] Furthermore, the amount of the additive added is about 2%-5% of the mass of the polyhydroxyalkanoate.

[0043] In a second aspect, the present invention provides a polyhydroxyalkanoate shaped body prepared from the polyhydroxyalkanoate composition according to the present invention.

[0044] The polyhydroxyalkanoate molded body of the present invention may include various forms, such as pellets, films, fibers, non-woven fabrics, straws, boards, paper plastics, sheets, etc.

[0045] The polyhydroxyalkanoate shaped body of the present invention can be prepared by a thermal processing molding method, or by a non-thermal processing molding method such as solution casting molding. Therefore, in a third aspect, the present invention also provides a method for preparing the polyhydroxyalkanoate shaped body.

[0046] In a specific embodiment, the method for preparing the polyhydroxyalkanoate molded body comprises the following steps:

[0047] (1) melting the uniformly mixed polyhydroxyalkanoate composition at a temperature higher than the melting point of the polyhydroxyalkanoate to form a melt;

[0048] (2) The melt in step (1) is crystallized at a temperature of 65° C. or below.

[0049] In a specific embodiment, in step (1) of the above preparation method, the melt temperature is 140-180°C.

[0050] In a specific embodiment, in step (2) of the above preparation method, the melt is crystallized at a temperature of 40°C or below, for example, 20 to 40°C.

[0051] In a specific embodiment, the polyhydroxyalkanoate molded article of the present invention can be prepared by various thermal processing molding methods such as extrusion molding, injection molding, calendaring molding, casting molding, blow molding, and biaxial stretching molding.

[0052] In a specific embodiment, the polyhydroxyalkanoate shaped body of the present invention is prepared into a particle shaped body by an extrusion granulation method, comprising the following steps:

[0053] (1) Melt extrusion: The uniformly mixed polyhydroxyalkanoate composition is melt extruded in an extrusion granulation device, and the temperature of the extrusion granulation device is set at 50 to 180° C.;

[0054] (2) Granulation: The melt extrudate is crystallized and granulated at a temperature of 65°C or below.

[0055] In the above-mentioned extrusion granulation method, in step (1), the extrusion granulation equipment can be selected from conventional granulation equipment in the art, such as parallel co-rotating twin-screw extruders with different aspect ratios, parallel counter-rotating twin-screw extruders, conical twin-screw extruders, and single-screw extruders. The temperature of the extrusion granulation equipment is set within the range of 50°C to 180°C, the main engine speed is 50-500r / min, and the feed rate or production capacity is adjusted according to the actual production status.

[0056] In a specific embodiment, while maintaining crystallization efficiency and processing effect, a crystallization temperature with lower energy consumption can be used. In step (2), the molten extrudate is crystallized and granulated at a temperature of 40°C or below, for example, 20°C to 40°C.

[0057] In a specific embodiment, in step (2), granulation can be performed by air-cooled strand pelletizing, water-bath strand pelletizing, grinding hot cutting, water ring cutting, underwater pelletizing, and other pelletizing methods.

[0058] In a specific embodiment, after step (2), the step of drying the prepared particles is further included. Specifically, the prepared particles can be dried using a blast drying oven to eliminate the influence of moisture on the particle performance and to ensure complete crystallization of the particles. Beneficial effects

[0059] (1) The present invention has found that lactic acid or its organic derivatives as nucleating agents can significantly increase the crystallization rate and crystallinity of polyhydroxyalkanoate when preparing molded bodies.

[0060] (2) Under normal circumstances, the crystallization temperature required for preparing polyhydroxyalkanoate molded bodies is about 40-65°C. In the present invention, lactic acid or its organic derivatives can reduce the crystallization temperature of polyhydroxyalkanoate with a wide melting range (20-40°C), effectively shorten the solidification time of the molded body, and have high nucleation efficiency. At the same time, by using a lower crystallization temperature, a molded body with better crystallization can be obtained without continuous heating, making the processing method simpler and effectively reducing energy consumption. DETAILED DESCRIPTION

[0061] In the field of thermoplastic processing, the crystallization of polymer materials is the process of partially arranging polymer chains on a microscopic level. During this process, the polymer chains fold up to form ordered areas, which are called lamellae. The lamellae can be stacked into larger spherical structures, called spherulites, thus forming macroscopic crystalline molded bodies. In the present invention, polyhydroxyalkanoate (PHA) is a polymer raw material with excellent full biodegradability. Its physical properties such as glass transition temperature, crystallization temperature, melting point, melting range, etc. are very different from those of other materials such as polyglycolic acid (PGA), polylactic acid (PLA), and poly-ε-caprolactone (PCL). In conventional processing, materials such as PLA can be easily and quickly crystallized and formed, but PHA, due to its lower glass transition temperature (PHA's Tg is about 0°C, PLA's Tg is about 60°C), often cannot be quickly crystallized and formed during processing.

[0062] Taking into account the particularities of polymer crystallization, the inventors specifically explored the effects of commonly used nucleating agents for polymer crystallization in the field of thermoplastic processing, such as some inorganic nucleating agents, including nano-calcium carbonate, nano-silica, terephthalic acid, titanium dioxide, hydrotalcite, boron nitride, etc., organic nucleating agents, such as specialized nucleating agents for polylactic acid (PLA) (such as TMC-306 and TMC-200), and lactic acid or its derivatives used in the present invention, on the crystallization effect of PHA, and found a more suitable solution for promoting PHA crystallization.

[0063] The following are detailed descriptions of specific embodiments of the present invention. It should be understood that the specific embodiments described herein are intended only to illustrate and explain the present invention and are not intended to limit the present invention. The present invention will be described in detail below through examples. In the following examples, unless otherwise specified, all materials used can be obtained commercially, and unless otherwise specified, the methods used are conventional methods in the art.

[0064] The endpoints of the ranges and any values ​​disclosed herein are not limited to the precise ranges or values, and these ranges or values ​​should be understood to include values ​​close to these ranges or values. For numerical ranges, the endpoints of each range, the endpoints of each range and individual point values, and the individual point values ​​can be combined with each other to obtain one or more new numerical ranges, which should be considered to be specifically disclosed herein.

[0065] The present invention is described in more detail by the following examples, which are not intended to limit the present invention. All raw materials used in the following examples and comparative examples are commercially available unless otherwise specified.

[0066] Raw materials and sources:

[0067] Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBH), product number: BP350, Beijing Lanjing Microbiology Technology Co., Ltd., 3HB (3-hydroxybutyrate unit) content 89%, weight-average molecular weight approximately 600,000-800,000.

[0068] L-lactic acid ((S)-2-hydroxypropionic acid), product number: L118493, Aladdin, >98.0% (T), refractive index 1.4260-1.4310, specific rotation -10.0-15.0 deg (C=2.5, 1.5 mol / L NaOH sol.).

[0069] D-lactic acid ((R)-2-hydroxypropionic acid), product number: S161106, Aladdin, >90.0% (T), refractive index 1.43, specific rotation 13° (C=2.5, 1.5 mol / L NaOH).

[0070] Methyl lactate (methyl DL-lactate), product number: M158854, Aladdin, >98.0% (GC), refractive index 1.413.

[0071] Ethyl lactate (ethyl α-hydroxypropionate), product number: E108230, Aladdin, 98.0% (GC), refractive index 1.4125.

[0072] Butyl lactate (butyl α-hydroxypropionate), product number: B111190, Aladdin, 98.0% (GC), refractive index 1.421, specific rotation -10.0-13.0 deg (neat).

[0073] equipment:

[0074] High-speed mixer: Zhangjiagang Zhengde Machinery Factory, model: SHR-50L.

[0075] Twin-screw extruder granulator: Nanjing Keya Chemical Equipment Co., Ltd., model: HK36.

[0076] Preparation method of polyhydroxyalkanoate particle molding in Experimental Examples 1 to 35:

[0077] Preparation of granular bodies: Twin-screw extrusion granulation was used; the polyhydroxyalkanoate composition formulas used in Experimental Examples 1-35 (components in the formulas are calculated in parts by mass) are shown in Tables 1 to 4, respectively. The specific preparation steps are:

[0078] (1) Mixing: Place polyhydroxyalkanoate powder and nucleating agent in a high-speed mixer, mix at room temperature, a mixing speed of 200 r / min, and a mixing time of 5 min; after mixing, place the mixture in the lower hopper of a twin-screw extruder;

[0079] (2) Melt extrusion: Set the conditions of the extrusion granulation equipment and perform melt extrusion at a melt temperature of 150°C;

[0080] (3) Granulation: Granulation was performed by using an underwater cutting system, wherein the water bath heating temperature was set as shown in Tables 1 to 4.

[0081] Performance evaluation method of the polyhydroxyalkanoate particle molded body in Experimental Examples 1 to 35:

[0082] Crystallinity:

[0083] Using a differential scanning calorimeter (DSC25, manufactured by TA Instruments), 2-10 mg of the polyhydroxyalkanoate composition was measured and heated from -50°C to 180°C at a rate of 10°C / min to obtain a DSC curve. Furthermore, data such as the glass transition temperature, melting temperature, melting peak area, and cold crystallization peak area were obtained from the DSC curve of the polyhydroxyalkanoate composition.

[0084] Crystallinity (%) = 100% × melting enthalpy / 100% crystallization melting enthalpy;

[0085] The 100% crystalline melting enthalpy is the theoretical thermal enthalpy of a 100% crystalline material. The greater the degree of crystallinity, the higher the crystallinity of the molded body, which is more conducive to subsequent processing and molding.

[0086] Difficulty of thermoplastic processing of particle moldings:

[0087] ○: Continuous and stable processing is possible, and the molded body solidifies in a short time.

[0088] △: Stable extrusion during thermoplastic processing, and the solidification time of the molded body is long.

[0089] ×: The extruder is unstable during extrusion, and the molded product takes a long time to solidify.

[0090] Weight average molecular weight:

[0091] The measurement was performed using a gel permeation chromatograph (HPLC GPC system manufactured by Shimadzu Corporation) using a chloroform solution and in terms of polystyrene. As the column for the gel permeation chromatograph, any column suitable for measuring the weight average molecular weight may be used.

[0092] The performance evaluation results of the polyhydroxyalkanoate particle molded bodies in Experimental Examples 1 to 35 are shown in Tables 1 to 4.

[0093] Example 1: Effects of Lactic Acid, Organic Lactic Acid Derivatives, and Similar Substances on Molded Body Nucleation

[0094] Table 1

[0095] It can be seen from Experimental Examples 1-8 that, compared with the blank control Experimental Example 8, the addition of lactic acid (Experimental Examples 1-3) and the addition of its organic derivatives (Experimental Examples 4-7) can improve the crystallization nucleation ability of PHA. In contrast, lactic acid has a more excellent crystallization nucleation ability, and its crystallization nucleation effect is much greater than the crystallization nucleation ability of lactic acid organic ester derivatives. In addition, the study found that the six-membered cyclic lactide formed as a lactic acid dimer can reduce the crystallinity of PHA (Experimental Example 4). It can be seen that the addition of the six-membered cyclic lactide without retaining the α-hydroxyl group to PHA does not play a role in improving the crystallinity. This also verifies that retaining the α-hydroxyl group of the organic lactic acid derivative can achieve a similar effect of promoting crystallization. Therefore, the present invention should not be limited to the specific organic lactic acid derivatives containing α-hydroxyl groups listed above.

[0096] Example 2: Effect of lactic acid and other existing nucleating agents on the molding effect of molded bodies

[0097] Table 2

[0098] Comparing Experimental Example 1 with Experimental Examples 9-19, it can be seen that lactic acid nucleating agents significantly improve crystallinity compared to other types of nucleating agents, and their nucleation efficiency is higher than that of other existing nucleating agents. Furthermore, compared to other existing nucleating agents, lactic acid raw materials are more readily available and have excellent applicability, resulting in molded articles with excellent environmental and biocompatibility.

[0099] Example 3: Effect of adding different weight portions of lactic acid on the nucleation effect and performance of the molded body

[0100] Table 3

[0101] As for crystallinity, the greater the crystallinity, the better the nucleation efficiency. It can be seen from Example 1 and Examples 20-30 that compared with the blank control Experimental Example 8, the crystallinity of the raw materials after adding lactic acid has been greatly improved. In the above experimental examples with an addition amount of 0.1-3 parts, lactic acid has the effect of promoting crystallization, which can make the crystallization effect better and the processability of the prepared molded body is also better. In this embodiment, the study found that when the addition amount of lactic acid is less than 0.01%, the effect is not obvious. When the addition amount of lactic acid is greater than 20%, it often causes the depolymerization of the resin and produces an odor. Therefore, the addition amount of lactic acid can be in the range of 0.01% to 20%.

[0102] Example 4: Other effects of lactic acid and other additives on the molding process

[0103] Table 4

[0104] The symbols have the following meanings:

[0105] ○: Continuous and stable processing is possible, and the molded body solidifies in a short time.

[0106] △: Stable extrusion during thermoplastic processing, and the solidification time of the molded body is long.

[0107] ×: The extruder is unstable during extrusion, and the molded product takes a long time to solidify.

[0108] By comparing the data in Table 4, it is found that when the crystallization temperature is lowered, that is, when the water bath temperature is set to 20°C-40°C (38°C), compared with the addition of additives such as behenic acid, boron nitride, 16-hydroxyhexadecanoic acid, and TMC-200 (Experimental Examples 32-35), the addition of lactic acid (Experimental Example 31) can effectively solidify PHA in a short time, improve processing efficiency, and reduce processing difficulty; it can be seen that when lactic acid is added, a lower crystallization temperature can be used, which not only ensures the crystallization quality of the molded body, reduces the curing time and improves efficiency, but also reduces the energy consumption of actual production.

[0109] Although the present invention has been described in detail above using general descriptions and specific embodiments, it will be apparent to those skilled in the art that modifications and improvements may be made based on the present invention. Therefore, such modifications and improvements, which do not depart from the spirit of the present invention, are intended to be within the scope of protection claimed herein.

Claims

1. A polyhydroxyalkanoate composition, include: Polyhydroxyalkanoate; and at least one of lactic acid or an organic derivative of lactic acid represented by the following general formula I: R 2 CH 2 -CH(OH)-COYR 1 I Among them, R 1 is H or a hydrocarbon group, R 2 is H or a hydrocarbon group, and Y is any one of C, O, N, and S.

2. The polyhydroxyalkanoate composition according to claim 1, It is characterized in that In the general formula I, Y is O, R 1 , R 2 H, respectively, that is, the composition includes lactic acid, and the lactic acid is selected from L-lactic acid, D-lactic acid or a combination thereof; In the combination of L-lactic acid and D-lactic acid, the ratio of L-lactic acid:D-lactic acid is 0.01 to 99.99:99.99 to 0.

01.

3. The polyhydroxyalkanoate composition according to claim 1, It is characterized in that In the general formula I, Y is O, R 1 is a C1-C16 hydrocarbon group, R 2 is H or a C1-C16 hydrocarbon group; or, In the general formula I, Y is O, R 1 For H, R 2 It is a C1-C16 hydrocarbon group.

4. The polyhydroxyalkanoate composition according to claim 3, It is characterized in that The organic lactic acid derivatives include methyl lactate, ethyl lactate, propyl lactate, butyl lactate, isopentyl lactate, benzyl lactate, tetradecyl lactate, hexadecyl lactate, methyl 3-phenyllactate, and 3-phenyllactic acid.

5. The polyhydroxyalkanoate composition according to any one of claims 1 to 4, It is characterized in that The added amount of the lactic acid and / or organic lactic acid derivatives is 0.01%-20% of the mass of the polyhydroxyalkanoate.

6. The polyhydroxyalkanoate composition according to claim 1, It is characterized in that The polyhydroxyalkanoate contains a structural unit represented by the following general formula II: Where R represents C p H 2p+1 The alkyl group shown in FIG. 1 , p represents an integer of 1 to 15, preferably an integer of 1 to 10, and more preferably an integer of 1 to 8; m is 1, 2 or 3.

7. A polyhydroxyalkanoate shaped body, prepared from the polyhydroxyalkanoate composition according to any one of claims 1 to 6.

8. The method for preparing the polyhydroxyalkanoate molded body according to claim 7, It is characterized in that The following steps are involved: (1) melting the uniformly mixed polyhydroxyalkanoate composition according to any one of claims 1 to 6 at a temperature higher than the melting point of the polyhydroxyalkanoate to form a melt; (2) The melt in step (1) is crystallized at a temperature of 65° C. or below.

9. The method for preparing a polyhydroxyalkanoate molded body according to claim 8, It is characterized in that In step (2), the melt is crystallized at a temperature of 40° C. or below.

10. The preparation method according to claim 8 or 9, It is characterized in that The polyhydroxyalkanoate shaped body is prepared into a particle shaped body by an extrusion granulation method, comprising the following steps: (1) Melt extrusion: The uniformly mixed polyhydroxyalkanoate composition according to any one of claims 1 to 6 is melt extruded in an extrusion granulation device, and the temperature of the extrusion granulation device is set at 50 to 180° C.; (2) Granulation: The melt extrudate is crystallized and granulated at a temperature of 20 to 40°C.

Citation Information

Patent Citations

  • Polyhydroxyalkanoate composition containing hydroxy acid nucleating agent, polyhydroxyalkanoate forming body and preparation method of polyhydroxyalkanoate forming body

    CN115232456A

  • Polyhydroxyalkanoate composition, application thereof and thermoplastic forming body

    CN115806733A

  • High-flowability polyhydroxyalkanoate composition, molded body and preparation method of high-flowability polyhydroxyalkanoate composition

    CN116855052A

  • Polyhydroxyalkanoate composition, polyhydroxyalkanoate forming body and preparation method of polyhydroxyalkanoate forming body

    CN117209980A

  • Poly(hydroxyalkanoic acid) and thermoformed articles

    US20090099313A1